BioPharma Credit PLC (LON: BPCP)
London
· Delayed Price · Currency is GBP · Price in GBX 67.78
-1.22 (-1.76%)
Jan 23, 2025, 2:14 PM BST
BioPharma Credit Revenue
BioPharma Credit had revenue of $79.15M USD in the half year ending June 30, 2024, with 4.22% growth. This brings the company's revenue in the last twelve months to $136.37M, down -38.22% year-over-year. In the year 2023, BioPharma Credit had annual revenue of $135.74M, down -37.78%.
Revenue (ttm)
$136.37M
Revenue Growth
-38.22%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
820.24M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 43.25B |
| London Stock Exchange Group | 8.59B |
| Barclays | 23.60B |
| 3i Group | 4.29B |
| Lloyds Banking Group | 18.56B |
| NatWest Group | 13.99B |
| Standard Chartered | 13.78B |
| Prudential | 8.66B |